Sign Up / Log In
Account
Online Pharmacy
Doctor Services
Health Centre
Bulk Purchase
Corporate
Anagrelide is commonly used to treat essential thrombocytopenia
Anagrelide is a cyclic adenosine monophosphate phosphodiesterase III inhibitor. It reduces platelet production and inhibits platelet aggregation at high concentrations such as in patients with Essential Thrombocytopenia.
Anaemia, Fluid retention, Dizziness, Tachycardia, Palpitation Diarrhea, vomiting, flatulence, abdominal pain, Rash, Fatigue
It is unsafe to consume alcohol with Anagrelide. Taking Anagrelide may lead to side effects such as dizziness, fatigue and tachycardia or palpitations. Hence, consumption of both Alcohol and anagrelide may lead to additive effects that could be dangerous.
Anagrelide may be unsafe to use during pregnancy. Animal studies showed toxicity to the fetal development, however, there are limited human studies regarding the effect of Anagrelide on fetus. It should only be used if benefits outweigh the risks. Please consult your doctor.
Excretion of Anagrelide in human milk is unknown. Available data in animals have shown excretion of anagrelide/metabolites in milk. Breast-feeding should be discontinued during treatment with anagrelide as the risk to the newborn/infant cannot be excluded.
Anagrelide commonly cause dizziness. If patient experiences side effects such as dizziness, it is not advisable to drive a car or operate machinery.
Anagrelide is contraindicated in patients with moderate to severe kidney disease especially with less than CrC 50mL/min.
Anagrelide is contraindicated in patients with liver failure. Please consult your doctor.